related announcements
News
-
Sen. Ossoff Pushing to Expand Cancer Screenings for Georgia Seniors
-
During the Month of the Military Child, Ernst Works to Increase[...]
Healthcare
MorphoSys AG
MorphoSys AG
05/11/2021 | Press release | Distributed by Public on 05/11/2021 14:05
MorphoSys and Incyte Announce First Patient Dosed in Phase 3 frontMIND Study Evaluating Tafasitamab Combination as a First-line Treatment for Diffuse Large B-Cell Lymphoma
Sharing and Personal Tools
Please select the service you want to use:
Smartlinks | MorphoSys AG | News | Health | Healthcare Policy | Science | Research | Politics and Policy | Healthcare Policy | Policy and Regulation | Business and Economy | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Top Company News | Mergers and Acquisitions | Business Announcement | Products and Services | Corporate Litigation and Regulation | Pharmaceuticals | Biotechnology and Medical Research Companies | London Stock Exchange (LSE) | Börse Frankfurt | Six Swiss Exchange | Wiener Börse (ATX) | Börse Berlin | Börse Düsseldorf | Börse München | Börse Stuttgart | OTC Markets | BX Swiss | Tradegate Exchange | XETRA | NYSE American | NYSE ARCA Equities | Turquoise | Börse Hamburg | Börse Hannover | Nasdaq Global Select Market | BZX Exchange | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | Börse Berlin Equiduct Trading | FINRA Alternative Display Facility (ADF) | Aquis Exchange | SIGMA X MTF | EuroTLX | NYSE Chicago | Euronext Block MTF
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact